# Using Machine Learning to Identify Unique Predictors of Alcohol and Cannabis Impaired Driving > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/machine-learning-impaired-driving-predictors/ > **Published:** 2026-03-24T15:26:08-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T15:55:47-04:00 > **Clinical Summary:** Explore machine learning impaired driving predictors in alcohol and cannabis use among young adults to improve risk assessment and safety. --- CED Clinical Relevance  #56Monitored Relevance  Early-stage or contextual signal requiring further evidence before action. 🔬 Evidence Watch  |  CED Clinic [Public Health](https://cedclinic.com/cannabis-mold-contamination-risks-recall-safety/)SafetyYoung AdultsRisk AssessmentMachine Learning Journal Alcohol, clinical & experimental research Study Type Clinical Study Population Human participants Why This Matters Impaired driving remains a critical safety concern as [cannabis legalization](https://cedclinic.com/the-forgotten-history-of-hemp-in-america/) expands, yet most risk assessment tools rely on limited predictor sets. This machine learning approach identifies previously unrecognized risk factors that could inform more precise clinical screening and intervention strategies. Clinical Summary This cross-sectional study analyzed 8 years of survey data from Washington state young adults (ages 18-25) who used alcohol (N=9,852) or cannabis (N=4,891) in the past month. Using regularized regression and random forest algorithms, researchers identified salient predictors of impaired driving from comprehensive variable sets. The machine learning approach revealed novel risk factors beyond traditional demographic and substance use patterns, though the study’s observational design limits causal inference and generalizability beyond this specific population. Dr. Caplan’s Take “While identifying risk factors is valuable, this doesn’t change my clinical approach to cannabis patients regarding driving safety. I still rely on direct patient education about impairment timing and individual response rather than predictive algorithms.” Clinical Perspective 🧠 Clinicians should continue comprehensive substance use screening that includes driving behaviors, particularly in young adult patients. This research may eventually inform development of more sophisticated risk assessment tools, but current practice should emphasize individualized patient education about impairment recognition and safe driving intervals. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Using%20machine%20learning%20to%20identify%20unique%20predictors%20of%20alcohol%20and%20cannabis%20imp...%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/41811226/) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/41811226/) [🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Using%20machine%20learning%20to%20identify%20unique%20predictors%20of%20alcohol%20and%20cannabis%20imp...%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/41811226/) [📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/) [📝 Read more on Substack](https://substack.com/@doctorapproved) [🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41811226/](https://pubmed.ncbi.nlm.nih.gov/41811226/) Table of Contents - [FAQ](#FAQ)[Who was studied in this machine learning research on impaired driving?](#Who_was_studied_in_this_machine_learning_research_on_impaired_driving) - [How did machine learning help identify risk factors for impaired driving?](#How_did_machine_learning_help_identify_risk_factors_for_impaired_driving) - [Do these impaired driving findings apply to all people who use cannabis?](#Do_these_impaired_driving_findings_apply_to_all_people_who_use_cannabis) - [Related](#Related) ## FAQ ### Who was studied in this machine learning research on impaired driving? The study used 8 years of survey data from young adults aged 18 to 25 in Washington state. It included 9,852 people who had used alcohol and 4,891 who had used cannabis in the past month. It was a cross-sectional study published in Alcohol, Clinical and Experimental Research. ### How did machine learning help identify risk factors for impaired driving? Researchers applied regularized regression and random forest algorithms to comprehensive sets of variables to identify the most salient predictors of impaired driving. This approach revealed novel risk factors beyond traditional demographic and substance use patterns. The summary does not list the specific new factors that were identified. ### Do these impaired driving findings apply to all people who use cannabis? Not necessarily. The study’s observational design limits causal inference, so the predictors it identified reflect associations rather than proven causes. It also limits how well the results generalize beyond this specific population of Washington state young adults aged 18 to 25 who used alcohol or cannabis in the past month. {“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “Using machine learning to identify unique predictors of alcohol and [cannabis impaired driving](https://cedclinic.com/cannabis-impaired-driving-research-safe-driving/).”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41811226/”, “about”: “alcohol clinical experimental research clinical study”, “isPartOf”: “Alcohol, clinical & experimental research”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Cannabis Use Disorder Treatment Europe Review](https://cedclinic.com/cannabis-use-disorder-treatment-europe-evidence-watch/) Review the latest evidence on [cannabis use disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/) treatments in Europe, highlighting clinical approaches and outcomes. [Read More](https://cedclinic.com/cannabis-use-disorder-treatment-europe-evidence-watch/) 12 Best Alcohol Stocks to Buy Right Now – Insider Monkey Discover top alcohol stocks with strong market potential, relevant for investors interested in the alcohol industry. Explore Stocks [New Clinical Insights on Cannabis and Patient Outcomes](https://cedclinic.com/new-clinical-insights-on-cannabis-and-patient-outcomes/) Gain updated clinical insights on [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) and its impact on patient health outcomes from recent studies. [Learn More](https://cedclinic.com/new-clinical-insights-on-cannabis-and-patient-outcomes/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).